Comparative study on muscarinic receptor binding characteristics of oral, transdermal and intravesical oxybutynin used for the therapy of detrusor instability（Times New Roman, 14pt, bold）
Shizuo Yamada
Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka 422-8526, Japan (Times New Roman, 12pt, Italic)
Urinary incontinence and other symptoms of lower urinary tract dysfunction are prevalent among the rapidly growing population. Although oral oxybutynin (Oxy) has been used to treat detrusor instability (DI), there………….. (Times New Roman, 10pt)
……………………………..
………………………
……………
……
<Instructions for Preparing Abstracts and CV>
Abstract and CV of the presenting author are to be submitted via e-mail only, in English, by September, 20th, 2016. It is the responsibility of the presenting author to ensure accuracy of content, spelling and presentation, as abstract and CV will be published exactly as submitted. Please ensure that the abstract and CV are complete and in its required format prior to submission. Before submitting an abstract, please carefully review the following abstract submission guidelines.
1. Abstracts must conform to the following outline:
(i).Abstract Title
(ii).Authors and Institutions
(iii).Abstract Text (as per instructions)
2. The abstract body is limited to less than 500 words (one page). References should be included in the text. Tables, figures or any other graphics are not permitted in the initial abstract submission. Abstracts must be submitted in MS Word (PC) format.
3. Identify the author who will be presenting the abstract at the Symposium. The corresponding author should be the presenting author.
4. Font style: Times New Roman (Title should be bold-faced type, and affiliation should be in italic), Font size: 14 point (Title), 10 point (abstract body)
Shizuo Yamada, Ph.D. Your Photo
(4cmx3cm, 300dpi)
Education:
Shizuoka College of Pharmacy, 1967-1971, B.A., Pharmacy
Shizuoka College of Pharmacy, 1971 -1973, M.S., Pharmacology
Shizuoka College of Pharmacy, 1973 – 1976, Ph.S., Pharmacology
University of Nottingham (Professor J.N. Hawthorne), 1975, Biochemistry
University of London (Professor D.A. Brown), 1975, Pharmacology
Postgraduate Training, Research and Staff Appointments:
・Postdoctoral Research Associate with H.I. Yamamura and W.R. Roeske, University of Arizona, College of Medicine (1978-1980)
・Assistant Professor, Shizuoka College of Pharmacy (1980-1989), Pharmacology
・Associate Professor, University of Shizuoka, School of Pharmaceutical Sciences, Pharmacokinetics and Pharmacodynamics (1990-2003)
・Visiting Professor, University of California (William M. Pardridge) (1994)
・Professor and Chairman, University of Shizuoka, School of Pharmaceutical Sciences, Pharmacokinetics and Pharmacodynamics (2003-present)
・Vice President and Regent Professor, University of Shizuoka (2011-present)
・Director (Professor), Center for Pharma and Food (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka
Research fields (interest):
Awards, Honors:
Editor and Editorial Advisory Board:
1996-present: A member of Editorial Advisory Board for Life Sciences (Elsevier)
2001-2002: Asia/Pacific Co-Editor for Pharmacology Reviews and Communications
2003-2004: Asia/Pacific Review Editor for Receptors and Channels
2004–present: A member of Editorial Board of Journal of Receptors and SignalTransduction
Publications:
Abstract Submission
Please submit your abstract and CV to the Conference Secretariat ( and ). (One page)